Prevalence, prevention, and treatment of microalbuminuria and proteinuria in children with sickle cell disease.
about
Angiotensin-converting enzyme (ACE) inhibitors for proteinuria and microalbuminuria in people with sickle cell diseaseAngiotensin-converting enzyme (ACE) inhibitors for proteinuria and microalbuminuria in people with sickle cell diseaseAngiotensin-converting enzyme (ACE) inhibitors for proteinuria and microalbuminuria in people with sickle cell diseaseThe glomerulopathy of sickle cell diseaseRenal function in infants with sickle cell anemia: baseline data from the BABY HUG trialRenal function in children suffering from sickle cell disease: challenge of early detection in highly resource-scarce settings.Hydroxyurea is associated with lower prevalence of albuminuria in adults with sickle cell diseaseSickle Cell Disease in the Post Genomic Era: A Monogenic Disease with a Polygenic Phenotype.Urinary albumin excretion is associated with pulmonary hypertension in sickle cell disease: potential role of soluble fms-like tyrosine kinase-1.Update on the use of hydroxyurea therapy in sickle cell diseaseGlomerular hyperfiltration and albuminuria in children with sickle cell anemia.Chronic kidney disease and albuminuria in children with sickle cell disease.Prevalence and correlates of microalbuminuria in children with sickle cell anaemia: experience in a tertiary health facility in enugu, Nigeria.Hydroxyurea treatment decreases glomerular hyperfiltration in children with sickle cell anemia.Persistent microalbuminuria in human immunodeficiency virus infected children in kano, Nigeria.Hydroxycarbamine: from an Old Drug Used in Malignant Hemopathies to a Current Standard in Sickle Cell Disease.Interventions for chronic kidney disease in people with sickle cell disease.Sickle cell nephropathy: challenging the conventional wisdom.Sickle cell nephropathy - a practical approach.Proteinuria is associated with elevated tricuspid regurgitant jet velocity in children with sickle cell disease.Transition from paediatric to adult care for patients with sickle cell disease.Deferasirox nephrotoxicity-the knowns and unknowns.Roles of APOL1 G1 and G2 variants in sickle cell disease patients: kidney is the main target.Interventions for chronic kidney disease in people with sickle cell disease.Changes in Urine Microalbumin-to-Creatinine Ratio in Children with Sickle Cell Disease over Time.Changes in urine albumin to creatinine ratio with the initiation of hydroxyurea therapy among children and adolescents with sickle cell disease.Improvement of medical care in a cohort of newborns with sickle-cell disease in North Paris: impact of national guidelines.Prevalence and determinants of microalbuminuria in children suffering from sickle cell anemia in steady stateBlood pressure abnormalities in children with sickle cell anemia.Cystatin C, Beta2 Microglobulin, N-Acetyl-beta-D-glucosaminidase, Retinol-Binding Protein, and Endothelin 1 Levels in the Evaluation of Sickle Cell Disease Nephropathy.Losartan for the nephropathy of sickle cell anemia: A phase-2, multicenter trial.Novel marker for the detection of sickle cell nephropathy: soluble FMS-like tyrosine kinase-1 (sFLT-1).Prevalence of Microalbuminuria in Adult Patients with Sickle Cell Disease in Eastern Saudi Arabia.
P2860
Q24187284-2755CFF0-6CD6-47C7-AB98-19552E810674Q24198791-2528EDE4-5B68-49D2-9B5F-A27CA0F39CFBQ24236018-122FFCF8-1BDF-49A0-945B-1B2D0D95708FQ27023071-C2BE162D-48DB-40A3-9060-2732063049A7Q33514216-A6702BE9-41C3-4232-B2F6-EF7DCA277710Q33583968-620944D9-1727-4ADF-87B4-E7CA06C52224Q33684601-87CAE62F-E523-4723-8C38-95244B2400CCQ33791764-7CC58CCD-8929-4606-85F7-383D0F928788Q34073285-99CD30CA-34A2-4B13-BE53-8DE0BB483C2EQ34737460-694500BD-37D7-4A48-9DAF-1F7179D5B58FQ35278672-55AF222A-066E-4396-8838-BDADA1425159Q35985880-D3CBE2CA-A22A-4A32-8FC0-627536CC0127Q36302477-A113C811-237C-49A5-BA27-E086ADB8CBA4Q36358491-24C5A2EF-C1AA-41FB-8DE6-5865A873B8DCQ37644838-E13C4B19-FD07-4759-AE82-74598404D556Q37677221-3A14F992-B3C2-438E-AE2D-AFCEF3985D0FQ37713880-3903E823-78BF-4F31-9844-C1735A13209AQ37825800-F3A90E22-25C1-45A8-A397-EED2E2F0DD4EQ37929278-F6F3F2CD-9BD5-4FFA-A35C-414ACBA4875EQ37944597-645129D3-CB24-47D1-863F-F2B5CC17B322Q38171853-A6EBAB33-6E6A-43DC-8B40-3A4F2688F159Q38232442-CFD0E8A7-BE41-4659-91BE-F0C02620DE57Q38682842-6330EEC6-1EBC-4127-BA6B-A541D9988590Q38696578-CFC032FD-6A11-451A-BFA1-7DA4EC98F6C5Q39256344-47FE1B98-7FC2-4502-8AF4-5250B2CDF2BCQ39371550-FB083EF6-B6AD-4CF9-96D9-A9452957DC37Q40721306-0C15DEEF-75B8-41BB-883E-B43512B4EA0CQ41509966-D69A0E0A-CABB-49B9-9B09-1EDABA149725Q46620043-AEF8F488-E606-47FD-A98E-8369640725A0Q47675922-3097E3F7-FF94-4B4B-9DE6-0D2EA86C1A16Q48315547-95DC648A-081B-4A22-99CF-E71489E1C388Q53396943-E4EFB4F1-9FFE-4059-9857-317F37448E41Q54974433-1AC5BA20-3038-4319-AC25-733ACF62E37B
P2860
Prevalence, prevention, and treatment of microalbuminuria and proteinuria in children with sickle cell disease.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Prevalence, prevention, and tr ...... dren with sickle cell disease.
@en
Prevalence, prevention, and tr ...... dren with sickle cell disease.
@nl
type
label
Prevalence, prevention, and tr ...... dren with sickle cell disease.
@en
Prevalence, prevention, and tr ...... dren with sickle cell disease.
@nl
prefLabel
Prevalence, prevention, and tr ...... dren with sickle cell disease.
@en
Prevalence, prevention, and tr ...... dren with sickle cell disease.
@nl
P2093
P1476
Prevalence, prevention, and tr ...... ldren with sickle cell disease
@en
P2093
Caterina Hernandez
Jennifer L Waller
Kathleen M McKie
Kathleen T McKie
Luis Ortiz
P304
P356
10.1097/MPH.0B013E3180335081
P577
2007-03-01T00:00:00Z